… antiplatelet therapy and type II endoleak were significantly related to a lack of aneurysm
shrinkage 6 months after EVAR. Multiagent antiplatelet therapy … multiagent antiplatelet therapy …

… shown that anticoagulation and antiplatelet therapy after endovascular aneurysm repair is
safe. There … compared with findings from patients on no anticoagulant or antiplatelet therapy. …

… Antiplatelet therapy, mandatory as secondary prevention of … We analyzed whether different
antiplatelet therapies were … Antiplatelet therapy with salicylates appears to be linked to a …

… of this study was to evaluate the safety and necessity of antiplatelet therapy on patients
with Stanford Type B aortic dissection (TBAD) who underwent endovascular aortic repair (EVAR). …

… endovascular aortic 88 repair (f/bEVAR) procedures, evidence on post-operative antiplatelet
therapy … 89 This study aimed to investigate the role of single antiplatelet therapy (SAPT) vs. …

… Key Findings: Discharge antiplatelet and anticoagulant regimen varies broadly across the …
fenestrated/branched endovascular aortic repair (F/BEVAR). Dual-antiplatelet therapy (DAPT) …

… Antiplatelet Therapy (DAPT) to endovascular … endovascular treatment and DAPT, critically
appraising the safety and efficacy data for various DAPT regimens with different endovascular …

… The aim of this study was to evaluate practice patterns of dual antiplatelet therapy after
complex endovascular aortic surgery and to investigate the effects of this therapy on 1-year …

… The aim of this study was to evaluate practice patterns of antiplatelet therapy after complex
endovascular aortic surgery and to investigate the effects of antiplatelet therapy on 1-year …

… The aim of the current secondary analysis was to evaluate if the initial benefit seen with 6
months of dual antiplatelet therapy compared to aspirin monotherapy would persist after …